Abstract Cancer Stem Cells (CSCs) or Tumor-Initiating Cells (TICs) are a small sub-
population of cells within the tumor, able to give chemio-and radio-resistance and cause the …

There are abundant sources of anticancer drugs in nature that have a broad prospect in
anticancer drug discovery. Natural compounds, with biological activities extracted from …

The discovery of antibiotics has revolutionized the medicine and treatment of microbial
infections. However, the current scenario has highlighted the difficulties in marketing new …

Plants represent a rich source of structurally diverse secondary metabolites, which can be
exploited in the development of new clinically important compounds. Indeed, due to their …

Chemotherapeutic agents are commonly used as neoadjuvant for breast cancer therapy.
However, there is evidence of treatment failure for most of patients due to acquired …

Complementary and alternative medicine (CAM) has been in use among cancer patients for
a long time. There are several types of CAM that are practiced in various parts of the world …

Cancer stem cells (CSCs) are drug-resistant and radiation-resistant cancer cells that are
responsible for tumor progression and maintenance, cancer recurrence, and metastasis …

Cancer stem cells (CSCs) are one of the most important origins of cancer progression and
metastasis. CSCs have unique self-renewal properties and diverse cell membrane receptors …

Breast cancer is the most prevalent type of cancer, the fifth leading cause of cancer-related
deaths, and the second leading cause of cancer deaths among women globally. Recent …

Abstract Ethnopharmacological relevance 22β-hydroxytingenone (22-HTG) is a
quinonemethide triterpene isolated from Salacia impressifolia (Miers) AC Smith (family …